PRODUCT DETAIL

Symbicort 160 mikrogamov/4,5 mikrogramov/inhalačná dávka

Code

8849B

MA number

14/0175/16-S

Product Form:

sus inh 1x120 dávok (inh.Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

AstraZeneca AB, Sweden

Therapeutic Class:

14 - BRONCHODILATANTIA, ANTIASTHMATICA

ATC:

R	RESPIRATORY SYSTEM
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A	ADRENERGICS, INHALANTS
R03AK	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK07	Formoterol and budesonide

Shelf life:

Container:

inhaler Al

Route of admin.:

Inhalation use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	06.04.2016
SPC:	SPC_Symbicort 160 mcg_4,5 mcg_04.2021.pdf
PIL:	PIL_Symbicort 160 mcg_4,5 mcg_10_2022.pdf
Safety feature	Yes
Data update:	06.08.2021